Genome-wide CRISPR-Cas9 screens identify mechanisms of BET bromodomain inhibitor sensitivity.

Estoppey, David; Schutzius, Gabi; Kolter, Christian; Salathe, Adrian; Wunderlin, Tiffany; Meyer, Amandine; Nigsch, Florian; Bouwmeester, Tewis; Hoepfner, Dominic; Kirkland, Susan

Estoppey, David; Schutzius, Gabi; Kolter, Christian; Salathe, Adrian; Wunderlin, Tiffany; Meyer, Amandine; Nigsch, Florian; Bouwmeester, Tewis; Hoepfner, Dominic; Kirkland, Susan.

Afiliação

Estoppey D; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Schutzius G; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Kolter C; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Salathe A; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Wunderlin T; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Meyer A; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Nigsch F; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Bouwmeester T; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Hoepfner D; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.
Kirkland S; Novartis Institutes for Biomedical Research, Basel 4056, Switzerland.

iScience ; 24(11): 103323, 2021 Nov 19.

Article em En | MEDLINE | ID: mdl-34805786

Palavras-chave

Cell biology; Chemogenomics; Molecular biology

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Diagnostic_studies Idioma: En Revista: IScience Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Suíça

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google